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CHARACTERIZATION OF THE BINDING OF WISTERIA FLORIBUNDA  
 
AGGLUTININ TO CHONDROITIN SULFATE  
 
YANG LIU 
ABSTRACT 
 Chondroitin sulfate proteoglycans (CSPGs) are found in specialized brain 
extracellular matrix structures termed perineuronal nets (PNNs). The chondroitin sulfate 
chains of these CSPGs are thought to have a strong effect on neuroplasticity, along with 
development, injury, and diseased states of the brain. Wisteria floribunda agglutinin 
(WFA) is a plant lectin used to identify PNN via staining; the pattern of this staining is 
changed upon schizophrenia. As such, one powerful method of probing the identity of the 
CS chains of PNNs and addressing what changes in CS identity occur during 
schizophrenia is to characterize the features of the CS which bind to the lectin.  
Methods for characterization of WFA-CS binding and their biological relevance 
were developed and evaluated. Commercially available CS was used to probe the binding 
affinity of the agglutinin to various regions of CS via hemagglutination inhibition assays 
and affinity gradient elution of CS bound to WFA. The size, sulfation extent, and 
fragment location in the CS chain from these eluates were determined using HILIC-LC-
MS. As commercial sources can be used to elucidate the binding specificity of WFA, but 
not the actual relevant binding partner of WFA within the brain, PNN CS extractions 
were performed with a modified method aimed at reducing the timescale at which PNN 
CS can be obtained so as to allow similar experimentation on CS directly from PNN. The 
results pave the way for further determination of WFA-CS binding. 
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INTRODUCTION 
 
1-1. Chondroitin Sulfate 
 Glycosaminoglycans (GAGs) are linear chains of repeating disaccharide units that 
are attached to proteins; the combination of proteins and their linked GAG chains is 
referred to as a proteoglycan. Proteoglycans are produced by the vast majority of 
mammalian cells, and many are then secreted into the extracellular matrix (ECM) or 
embedded into membranes to control tissue and ECM properties such as resistance to 
compression, and to aid in signaling. Proteoglycan diversity stems from differences in 
core proteins, number of GAG chains linked, and diversity in the structure and chemical 
composition of GAG chains [1]. The GAG portions of proteoglycans interact with other 
molecules predominantly through charge-based interactions, which change with variable 
sulfation.  
Chondroitin sulfate is a variably sulfated GAG composed of repeating 
disaccharide units of −GlcA(β1,3)GalNAc(β1,4)− (glucuronic acid and N-
acetylgalactosamine). Biological chains of chondroitin sulfate range from 20 kDa to 50 
kDa, depending on the protein to which the chains are appended. It has three sites of 
sulfation which lead to four major types depending on the location of the sulfate group 
(Figure 1).  
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Figure 1. The types of chondroitin sulfate. Chondroitin sulfate A, B, C, D, and E are 
depicted. Of these, D and E are disulfated, while A, B, and C are monosulfated. 
Sulfation sites are not the only variable in CS structure; chain termination during 
biosynthesis can result in either GalNAc or GlcA at the non-reducing end. Briefly, the 
biosynthesis of CS occurs on serine residues of core proteins, where initially, a linker 
section is appended. The first GalNAc is then appended, giving the chain specificity to 
CS, following which the chain is polymerized by specific glycosyltransferases in an 
alternating pattern of GlcA and GalNAc. Chain termination occurs when non-reducing 
end GalNAc 4-S or GlcA preclude the addition of GlcA and GalNAc respectively, 
resulting in variably ending chains. Further variations of the terminus come from 6-
sulfation, which appears to occur by a separate sulfotransferase. In addition, a putative 
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glucuronidase may also act post-termination to remove GlcA and leave GalNAc at the 
non-reducing end [2]. Differences in the non-reducing end have been demonstrated in 
aggrecan from cartilage; the change in the prevalence of certain non-reducing end 
residues through aging suggests biological relevance and function [3]. 
Chondroitin sulfate plays numerous biological roles based on interactions 
predominantly occurring in the ECM [4]. One such location is in the brain, where they 
are appended to a subset of specialized ECM proteins that help guide neuronal 
development. 
  
1-2. Perineuronal Nets 
 Perineuronal nets (PNNs) are specialized ECM components that ensheath certain 
subpopulations of neurons in the brains of many species of mammal, including humans 
[5]. They appear with brain maturation and function to control neuroplasticity; their 
establishment helps to inhibit axonal growth and promote brain maturation [6, 7]. PNNs 
are composed of a large variety of proteins secreted from nearby cells (Table 1) [5, 8, 9]. 
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Component Structure Function 
Hyaluronan Linear polysaccharide Anchorage to cell surface 
Link proteins Small ECM proteins Structural integrity of PNN 
Aggrecan 
CSPG 
Inhibiting neuroplasticity 
and axonal growth; scaffold 
for growth factors and other 
signaling molecules 
Versican 
Brevican 
Neurocan 
Tenascin-R Modular glycoprotein Structural integrity of PNN 
 
Table 1. Components of PNN. Describes the components of PNN, along with their 
structure and function. 
Among these are the chondroitin sulfate proteoglycans (CSPGs), comprised of 
aggrecan, brevican, neurocan, and versican, which link to hyaluronan, tenascin-R, and 
link proteins within the matrix [10]. These proteins are upregulated during brain 
maturation, and the chondroitin sulfate chains of these proteins have been demonstrated 
to change, with 6-sulfation (CSC) disappearing, while 4-sulfation (CSA) increases [11]. 
The chondroitin sulfate chains are of significant note; chondroitinase ABC (ChABC) 
treatment of brain regions restores the neuroplasticity of those regions [6, 12]. As such, 
probing changes in chondroitin sulfate structures from the PNN would shed light on their 
influence over neuronal development and disorders. 
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1-3. Wisteria floribunda agglutinin 
 Lectins are proteins with carbohydrate recognition domains which generally 
recognize terminal segments of glycan chains with variable affinity. Commercially used 
lectins are predominantly extracted from plants; many of these lectins are named 
agglutinins for their ability agglutinate hemocytes [14]. Commercial plant lectins are used 
as tools in glycoanalysis to help identify glycans, sort cells, and to perform histochemical 
staining [15]. 
 One such lectin is Wisteria floribunda agglutinin, a 120 kDa plant lectin extracted 
from the seeds of the Japanese wisteria, W. floribunda. Biotin-conjugated WFA is 
employed in the staining of brain tissue, along with a few other tissues such as cartilage, 
where the staining delineates different regions of the tissue [15-17]. In brains, WFA 
labels CSPGs, as demonstrated by the abolishing of WFA labeling upon treatment with 
ChABC [18].  
WFA labels PNNs in rodents with great specificity, and is used as a marker for 
PNNs, despite CS being present throughout the brain [19]. In addition to PNN, WFA-
CSPG labeling stains a subpopulation of astrocytes in the human amygdala; evidence 
points to astrocytes being a species specific source of CSPGs [20]. Intriguingly, this 
staining is altered in the brains of schizophrenic persons, where there is a marked 
increase in CSPG and corresponding WFA labeling around astrocytes, along with a 
significant decrease in labeling of PNNs [21]. This, along with the evidence of CS effects 
on neuroplasticity and brain development as a whole, suggests that CS has an important 
function in the brain in the context of schizophrenia. Furthermore, CSPG production is 
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increased in glial cells, yet the staining of WFA has decreased, suggesting the possibility 
that the CS chains themselves are altered and have different binding specificity. As such, 
elucidation of the binding partners of WFA would yield great insight into the function of 
CS and its transformation throughout development, injury, and disease. 
Previous literature on the binding affinity of WFA suggests that it is broadly 
specific to terminal GalNac independent of linkage [22, 23]. However, studies have yet to 
be done to elucidate the structure or binding specificity of WFA to longer chain 
polysaccharides such as GAGs. Therefore, the focus of this thesis is to determine the 
binding specificity of WFA so as to aid in precisely characterizing the CS present in the 
brain. The method selected is a protein-glycan binding assay which utilizes mass 
spectrometry for GAG identification. 
 
1-4. Protein-glycan binding experiments 
Protein-glycan binding experiments are a demonstrated method by which the 
glycan partners of an interacting protein can be purified. The general method involves 
incubating the protein with a library of the GAGs in question, immobilizing the protein 
component onto a hydrophobic trapping column, then eluting the GAGs on the basis of 
affinity with a step gradient of salt wash. The GAGs can then be characterized via mass 
spectrometry. 
This method has previously been applied with success to antithrombin III and 
HIV envelope protein gp-120 with regards to their HS binding specificities (previously 
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unpublished data) [24]. Data from the latter are presented as further verification of the 
method (Figure 2). 
 
Figure 2. Percentage of total signal by sulfation degree. A HS library was generated 
via lyase digestion and SEC separation. A pool of dp10 to dp12 was incubated with HIV 
envelope protein gp120, which requires a mimic CD4 peptide to bind HS. The complexes 
were bound to a reversed phase cartridge. HS was eluted with a 200 mM ammonium 
acetate wash. Chains of HS dp 10 of identical composition save for degree of sulfation 
were identified and selected for a comparison of the effect of sulfation on binding affinity 
to gp120. It was determined that gp120 likely preferentially binds HS with higher degrees 
of sulfation. 
In both cases, a specific range of sulfation having higher affinity for the protein 
binding sites was discovered. Given that differences in sulfation were identified as a 
means by which CSPGs alter neuroplasticity, it is possible that WFA similarly recognizes 
an extent or pattern of sulfation. A modified version of this binding experiment was 
performed to probe this possibility. 
 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
8 9 10
 
11
 
12
 
13
 
14
 
15
 
P
er
ce
n
ta
ge
 o
f T
ot
al
 
Sulfation Degree 
Sulfation of Input and gp120 Binders Input library gp120 binders 
7 
 
1-5. Mass spectrometry 
 Mass spectrometry is a highly sensitive analytical technique used for determining 
the composition and structure of analytes. The mass spectrometer itself has three essential 
components – an ion source to ionize the sample, a mass analyzer to separate ions by 
their mass-to-charge (m/z) ratios, and a detector which detects the separated ions and 
outputs analytical data. Figure 3 is a flow chart that summarizes the process of preparing 
and analyzing a sample via mass spectrometry. 
 
Figure 3. General workflow for a mass spectrometry experiment. Samples are 
prepared as necessary and cleaned to avoid contaminants. Chromatographic separation of 
some form separates analyte by some characteristic (charge, size, etc). The analytes, upon 
eluting and moving to the ion source, are ionized and fragmented; the ions are then 
separated by m/z ratios in an analyzer. The currents of separated ions are then uniquely 
measured by the detector, which produces data in the form of m/z vs. acquisition time for 
downstream data analysis. 
 Ions can be produced for mass spectrometry using a technique called electrospray 
ionization (ESI). In ESI, a solubilized analyte is pushed through a nano/micro-capillary 
and is subjected to a high potential difference between the end of the capillary and the 
mass analyzer entrance. This results in an aerosol of highly-charged droplets that enter 
the low-pressure mass spectrometer. The solvent evaporates, leaving the droplets smaller 
and increasing the repulsive electrostatic interactions between ions inside each droplet. 
This increase in repulsion causes droplets to split and evaporate, forming a spray of ions 
that can be analyzed using MS [25].  
Upstream 
sample 
prep
Chromato-
graphic 
separation
Ionization 
in ion 
source
Mass 
separation 
in analyzer
Ion 
detection
Data 
analysis
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 Data produced by mass spectrometry of heterogeneous mixtures of glycans can be 
complex, requiring a great deal of time to analyze; signal can be lower than that which is 
easily interpretable by the human eye. Software is available to deconvolute data 
generated from mass spectrometry, such as DeconTools, provided by the Pacific 
Northwest National Laboratories. Post-deconvolution, the data still need to be processed 
so as to match observed masses oligosaccharide identities. GlycReSoft is a glycan-
analysis software which aims to automate the process, building a list of masses 
corresponding based on compositional parameters set by the user [26]. Its versatility in 
mass list generation is invaluable to the analysis of the complex spectra of 
oligosaccharides. 
 
1-6. Brain GAG extraction 
 In order to directly analyze CS from the brain, and more specifically, from the 
PNNs, the CS analyte must be sourced from the brain itself. As rat brains are readily 
available and their PNN WFA labeling is specific, they make a perfect model tissue for 
the development of the techniques needed to extract brain GAGs before performing 
extractions on more precious human-derived sources. Previous literature describes a 
method by which brain GAGs can be separated by their origin into three fractions – 
intracellular soluble GAGs, membrane-bound GAGs, and PNN GAGs using sequential 
extractions with selective buffers [27].  
For the purpose of characterizing the GAG chains, much greater quantities must 
be extracted in a relatively shorter period than the previous method yielded. For this 
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reason, a subfocus of the project was the development of a protocol that would eliminate 
steps in the process that served only to protect protein structure while still providing 
similar yield.  
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EXPERIMENTAL PROCEDURES 
 
2-1. Commercial CS library construction 
 Bovine trachea CSA was obtained from Sigma; shark cartilage CSC was obtained 
from Seikagaku. Forty mg of CSA and CSC were desalted via dialysis overnight using 
Slide-a-Lyzer 3.5K MWCO cutoff dialysis cassettes (Thermo Scientific), then dried 
down and weighed with a recovery of 25 mg. The CS was then digested using ChABC 
(Seikagaku) in the manufacturer’s recommended buffer (100 mM Tris, 0.1M NH4OAc 
with 0.01% BSA); the reaction was monitored via UV spectrophotometry at 232 nm and 
quenched with 60 mM HCl at 30% completion, generating a mixture of oligosaccharides 
to disaccharides. 
The digestion products were then applied to a 170 x 1.5 cm Bio-Rad Econo 
column packed with P-10 gel, 45-90 μm particle size, for SEC separation in a running 
buffer of 100 mM sodium bicarbonate. SEC separation was carried out at a flow rate of 
0.1 ml/min, the effluent was monitored via UV at 232 nm and fractions were collected 
until disaccharides eluted (confirmed via disaccharide analysis). The UV trace was used 
to determine the relevant fractions and estimated sizes of GAG fragments; further UV 
measurements of individual fractions were used to estimate quantity per fraction. Mass 
spectrometry on an ABI QStar Pulsar I, as described in subsection 2-5, was then 
performed to confirm the fractions containing disaccharides; the identity of the other dps 
were  determined using an Agilent 6520 as detailed in subsection 2-6. 
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2-2. Hemagglutination inhibition assay 
Biotin-labeled WFA was obtained from the laboratory of Dr. Sabina Berretta at 
McLean Hospital, Belmont, MA, originally purchased from Vector Laboratories. The 
identity and intact structure were confirmed by molecular weight measurements via 
PAGE and SDS-PAGE. Samples of 400 nmol, 200 nmol, 100 nmol, and 50 nmol of full 
length CSC and CSA were incubated with WFA or heat-inactivated WFA (10 min boil) 
in PBS at room temperature for 30 minutes, then applied to porcine red blood cells 
(RBCs) obtained from Lampire Biological Laboratories in round-bottomed 96-well plates 
in 1X PBS. The plates were then agitated on a rocker for 1 hour before qualitative visual 
result interpretation. The same method was applied to test the binding capability of 10 
nmol and 20 nmol of full length CSA versus dp 5-6 and dp 7-8 fractions. The 
experiments were performed in technical triplicates. 
 
2-3. CSA fraction quantification 
CSA fractions corresponding to dps 5-6 and dps 7-8 were pooled as equal 
volumes from identified fractions, dried down and quantified via carbazole assay as 
described previously [28]. The pooled, dried fractions were resuspended in 200 μl MilliQ 
H2O, along with CS disaccharide standards of 10, 25, 50, and 100 nmol. The samples 
were transferred to Pyrex reaction tubes with PTFE-lined caps; ammonium sulfamate was 
then added. A stock solution of 25 mM sodium tetraborate in H2SO4 was prepared and 
added to the reaction tube, which was then heated at 100°C for 5 min before 0.1% 
carbazole was added, after which the tubes were heated for a further 15 min. After 
12 
 
cooling, the reaction mixtures were pipetted into a round-bottomed 96 well plate, and the 
absorbances at 540 nm were measured. A standard curve was prepared using the CS 
disaccharide standard, and the concentrations of pooled CSA dp 5-6 and dp 7-8 were 
determined. 
 
2-4. WFA-CSA binding experiments 
  100 nmol of the quantified pooled dps were incubated with 10 nmol WFA or heat-
inactivated WFA in MilliQ H2O at room temperature with rotation for 1 hour before 
being applied to equilibrated C-18 MacroSpin Columns obtained from The Nest Group. 
Charged and polar analytes were eluted with 100 ul of 100 mM, 200 mM, 500 mM, 1 M, 
or 2 M ammonium acetate, and the eluates collected.  The eluates were then subject to 
several rounds of drying and resuspension to remove ammonium acetate before final 
resuspension for mass spectrometric analysis. 
 
2-5. PNN GAG extractions 
 Rattus norvegicus brains were generously provided by the laboratory of Dr. 
Sabina Berretta and stored at -80°C. For extraction, the brains were thawed, then 2-4g 
brains were homogenized using a Tenbroeck glass homogenizer in 50 mM TBS, pH 7.0 
(buffer 1). The homogenized brain mixture was then centrifuged at 20000 x g for 20 
minutes, and the supernatant, containing soluble GAGs and glycoproteins, was collected. 
The pellet was homogenized in buffer 1, and then centrifuged two more times; the first 
two supernatants were pooled and the last discarded. The process was repeated with 
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buffer 2 (buffer 1 with 0.5% Triton-X100) for membrane bound GAGs, and buffer 3 
(buffer 2 with 1M NaCl) and buffer 4 (buffer 2 with 6M urea) for PNN GAGs. 
 After supernatant collection, the extracts were dialyzed for 24 hours against a 
buffer solution of 0.2 M NaCl and 50 mM Tris (running buffer), pH 6.0 in Pierce 
SnakeSkin dialysis tubing with a 3.5K MWCO to remove salts and small molecule 
contaminants. Post-dialysis, extracts were digested with Pronase overnight at 37°C, then 
centrifuged at 20000 x g to pellet proteins. The supernatant was filtered through an 
Amicon 0.22 μm filter and applied to a 16/20 DEAE-FF column purchased from GE Life 
Sciences linked to a Fisher Variable Flow Rate Pump. The sample was washed with the 
running buffer; GAGs were eluted with a buffer of 1M NaCl, and the first 1.5 column 
volumes were collected. The collected GAG fractions were then concentrated with 
Amicon Ultra-15 Centrifugal Units with a 3.5K MWCO via centrifugation at 5000 x g in 
a fixed angle rotor centrifuge at 4°C. The GAGs were then precipitated via ethanol 
precipitation, with GAG-containing solution to ethanol with 0.2 M potassium acetate 
(1:3, v/v). 
 GAGs extracted with buffer 3 from a single rat brain were selected for 
confirmation of the success of this modified protocol and rough quantification of yield. 
The GAGs were digested with ChABC in the same process as detailed in subsection 2-1, 
but the reaction was allowed to reach completion overnight. The reaction was then 
centrifuged at 20000 x g for 10 minutes to pellet proteins; the supernatant was taken for 
disaccharide analysis as detailed in subsection 2-6. 
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2-6. Disaccharide analysis by nano-LC/MS 
 Mass spectrometry for disaccharide analysis was performed with an ABI QStar 
Pulsar-i Q-TOF with a TurbolonSpray Source providing ionization, coupled to a Acquity 
UPLC system with a Superdex peptide PC 3.2/30 SEC column (GE Life Sciences) for 
separation with UV monitoring at 232 nm. Samples were injected via an autosampler into 
the LC, and eluted at a rate of 0.015 ml/min. A CS standard was created, composed of 
100 pmol each of unsulfated, monosulfated, and disulfated CS dp2, and run in the same 
manner. Resultant spectra were manually interpreted in AnalystQS.  
 
2-7. Mass spectrometry of oligosaccharides 
 Mass spectrometry for oligosaccharide analysis was performed on an Agilent 
6520 Q-TOF with a coupled Agilent HPLC-Chip Cube for nanoelectrospray as described 
previously [29]. Briefly, chromatographic separation was achieved on an Agilent HPLC 
chip packed with Amide-80 stationary phase. The HILIC mobile phases were solvent A, 
consisting of 50 mM formic acid in 10% acetonitrile, pH 4.4 with adjustment using 
ammonium hydroxide; and solvent B, consisting of 95% acetonitrile and 5% solvent A. 
The make-up flow composition was 100% acetonitrile. CS oligosaccharides were loaded 
onto the chip with an intitial solvent composition of 80% B for 9.5 min, then a linear 
gradient of 80% B to 0% B was run to elute samples for 39 min before a wash at 0% B 
for 10 min. Then, the solvent composition was restored to 80%B and equilibrated for 7 
min. Water blanks were run between all samples to prevent carryover. 
15 
 
 A test build of GlycReSoft 2 was used to analyze the data. Data files were first 
deconvoluted using DeconTools (Pacific Northwest National Laboratories), then 
imported into GlycReSoft 2. A composition hypothesis file was generated with 
anticipated possible glycan species; glycosylamine formation was also accounted for.  
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3-1. CSA and CSC Library Generation 
 CSA and CSC libraries were generated via incomplete ChABC digestion and SEC 
separation. Figure 4 shows the UV trace from the chromatography of the relevant CSA 
size range with sizes identified. 
 
 
Figure 4. UV trace of SEC fractionation of ChABC digested CSA. The portion of the 
trace relevant to experiments in this thesis is shown above. Assignments for the fractions 
were determined by manual analysis of corresponding mass spectra. 
 
3-2. Hemagglutination inhibition 
 Hemagglutination inhibition has previously been used as a simple, effective 
method of studying the binding affinity of WFA to galactose [22, 30]. A 
hemagglutination inhibition assay was performed to assess the differences between CSA 
and CSC binding capability. Briefly, WFA was incubated with varying amounts of full 
dp 5-6 
dp 7 
dp 8 
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length bovine trachea CSA and shark cartilage CSC, added to porcine red blood cells 
(RBCs, from Lampire Laboratories) in PBS, and the results analyzed visually. The results 
are summarized in Table 2. 
 Boiled WFA 0 nmol CS 400 nmol CS 200 nmol CS 100 nmol CS 50 nmol CS 
CSA +++ - - - ++ ++ 
CSC +++ - ++ - - - 
 
Table 2. WFA hemagglutination inhibition of CSA and CSC. Porcine RBCs were 
treated with WFA and variable amounts of CSA and CSC. The inhibition measures the 
binding of CS to WFA, thus inhibiting the ability of WFA to bind RBC glycans. Without 
the effect of WFA, the RBCs form clumps at the bottom of the well; hemagglutination 
causes the blood to appear diffuse throughout the well. +++ = maximum inhibition as set 
from heat inactivated WFA. 
As expected, full length CS was able to bind WFA and inhibit its binding to 
RBCs. Interestingly, the results suggest that binding capabilities differ between CSA and 
CSC; CSA inhibits hemagglutination at lower concentrations, while it takes a very large 
amount of CSC to achieve the same inhibition, suggesting that CSA is preferred. Also 
noteworthy is that at concentrations above 100 nmol, CSA loses its ability to inhibit 
hemagglutination; this may be due to network formation, as long chain CS may have 
multiple WFA binding sites. 
Due to CSA’s higher binding affinity, as demonstrated through hemagglutination, 
WFA-CSA binding was chosen for further analysis. A similar hemagglutination 
inhibition assay was performed on ChABC digested, SEC-fractionated CSA (Table 3). 
Pools of dp 5-6 and dp 7-8 from the SEC-fractionated digestion library were selected to 
18 
 
avoid non-specific or multivalent interactions, and lower amounts of CS added per the 
results from the full length experiment. 
 10 nmol (disaccharide) 20 nmol (disaccharide) 
Full length CSA ++ ++ 
dp 5-6 + ++ 
dp 7-8 - + 
 
Table 3. Variability of WFA-CSA binding based on fragment length. 
Hemagglutination was performed with full length, dp 5-6, and dp 7-8 CSA. 
Qualitiatively, dp 7-8 was less able to inhibit hemagglutation compared to both full 
length CSA and dp 5-6 fragments. The amount in nmol was calculated by disaccharide 
mass, as it is not possible to estimate chain lengths of full length CSA. This approach 
prevents bias from number of free binding sites dependent on chain length, as there could 
be more than one binding site on the full length CSA. 
Qualitatively, neither fragment was as effective in inhibiting hemagglutination as 
the intact chain. Interestingly, WFA appears to have a slightly greater affinity to pooled 
dp 5-6 compared to dp 7-8; this may be the result of size, structural, or compositional 
preferences, as the pooled fractions differ in all accounts. 
 
3-3. Observation of GalNAc loss and glycosylamine formation in CSA fragments 
 Before automated data analysis could be performed for WFA-CSA binding 
experiments, any anomalies present in the spectra had to be manually interpreted. One 
anomaly appeared to be some form of peeling reaction that happens in ammonium 
bicarbonate. ChABC cleaves CS between GalNAc and GlcA; when internal, this leaves 
an unsaturated GlcA on one end and a GalNAc on the other, which, by necessity, leads to 
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even number dps. Figure 5A gives the stucture of this dp 6. CS chains are expected to 
terminate in a GalNAc at the non-reducing end, thus leading to odd numbered dps. 
However, m/z values corresponding to aberrant, internal odd number dps were found in 
the spectrum, as seen in Figure 6; in this case, the dp 5 correlates to the structure shown 
in Figure 5B. 
 
 
Figure 5. Structures of internal fragments corresponding to ChABC digested dp 6 fragments. A. 
Expected even numbered internal dp 6, indicating correct cleavage site. B. Abnormal odd numbered 
internal dp 5, indicating loss of GalNAc. In this case, squares indicated GalNAc, while diamonds indicate 
GlcA. 
 
Figure 6. Example of odd numbered internal fragment. The m/z value corresponds to 
an internal dp 5, which cannot by produced by ChABC digestion alone. The sample 
comes from a fraction of dp 6, which was not subject to other experimentation. 
 Similar losses are ubiquitous in all examined fractions (dps 5-8), and are unlikely 
to result from downstream experimental conditions, as the input has a significant amount 
A. 
B. 
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of these species. The losses are seen in saccharides that contained the non-reducing ends 
of the GAG chains, leading to even numbered fragments. Furthermore, the loss seems to 
progress with time, as the proportion of fragments with incorrect lengths increased over 
the span of three months on storage at -20°C; the increase was also observed when the 
samples were left at 27°C for a few hours after thawing. The GalNAc loss was 
determined not to be the result of any loss during the ionization process, as the proportion 
lost varied with storage and thaw times. 
SEC separated CSA and CSC were stored in the 100 mM ammonium bicarbonate 
solutions in which they were eluted. Fractions for analysis were dried down in a speedvac 
that does not feature adequate temperature control, and estimates of temperature reach up 
to 45°C. Ammonium bicarbonate is mildly alkaline; this, in conjunction with mild heat, 
may have been enough to induce a peeling reaction as has previously been described, 
though peeling generally requires more basic conditions [31]. It is also possible that the 
concentration of ammonium bicarbonate increased during the drying process, leading to 
significantly more basic conditions than the storage condition, facilitating peeling. 
 In addition to GalNAc loss, glycosylamine formation was observed. 
Glycosylamine formation has previously been observed for HS in ammonium 
bicarbonate, and is characterized by a ~1 Da shift lower in mass compared to the sugar it 
was derived from [32]. Figure 7 gives one example of glycosylamine formation from the 
samples. 
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Figure 7. Glycosylamine form of the internal dp 5 post-WFA binding experiment. A 
1 Da shift occurs at the internal dp 5 following WFA binding. The original peak appears 
to have been entirely converted to glycosylamine. 
 Interestingly, the glycosylamine formation affects the “peeling” products 
preferentially; original, full-sized ChABC digestion products do not seem as susceptible 
to this process. Furthermore, the glycosylamine derivative is not seen to increase in 
proportion over long-term storage or thawing of the CSA fragments, despite previous 
literature describing the reaction taking place in ammonium bicarbonate. Instead, it is 
observed exclusively in eluates from WFA binding experiments. This suggests that some 
other mechanism may be the cause for the glycosylamine formation. 
 Due to the presence of peaks corresponding to these derivative forms in the 
spectra, the parameters set in GlycReSoft were changed to accommodate 1 Da decreases 
in mass. 
 
3-4. WFA-CSA binding experiments 
WFA-CSA binding experiments were performed with CSA dp 5-6, as the fraction 
appeared to perform better in the qualitative hemagglutination inhibition assays, as seen 
in section 3-2. A pool of CSA dp 5-6 was taken from the SEC-fractionated digestion 
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library, dried to remove ammonium bicarbonate, and resuspended in water. A 100 nmol 
quantity of the pooled dps were incubated with 10 nmol WFA, and then applied to a 
reversed phase spin column, from which the CSA fragments were eluted by an increasing 
step gradient of ammonium acetate. The compositions and their relative abundances of 
the input dp 5-6 pool and salt eluates were determined using HILIC-LC/MS, with 
automated analysis being performed using GlycReSoft 2. Figure 8 gives the compositions 
and relative abundances of components in the input, 100 mM salt eluate, and 2M salt 
eluate, while Figure 9 gives a comparison of their percent compositions. Only these 
particular steps in the gradient were selected for analysis, as 200 mM and 500 mM were 
devoid of detectable CS-related signal. 
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Figure 8. Comparison of compositions between dp5-6 input library and salt eluates 
on the basis of signal intensity. CSA dp 5-6 was incubated with WFA, then eluted with 
a step gradient salt wash. Compositions are given in the form [ΔHexA, HexA, HexNAc, 
SO3]. The top fifteen compositions are shown in order of abundance. 
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Figure 9. Input and eluate compositions on the basis of percentage of total CS 
fragments. Abundances of glycans recognized by GlycReSoft 2 were summed, and 
percentages of the total were taken per unique identity. Compositions comprising over 
0.5% of the total were graphed for comparison. 
  
The most abundant species in all three samples was [1, 2, 3, 3]; this is expected, 
as [1, 2, 3, 3] is an internal dp 6, which would be favored in a pool of equal volumes but 
unequal concentrations, in which fractions containing dp 6 were noticeably higher 
concentration (see Figure 4). Furthermore, internal dps are generally more abundant, as 
each chain has only one terminal end, but is likely to generate multiple internal 
fragments. Beyond the single most abundant species, however, the identities begin to 
change. The shorter dps elute in greater proportions at the lower concentration salt wash, 
suggesting low-affinity, non-specific binding. In the 2 M eluate, the profile of detected 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
[1
, 4
, 5
, 6
] 
[1
, 4
, 5
, 5
] 
[1
, 4
, 5
, 4
] 
[1
, 4
, 4
, 4
] 
[1
, 3
, 4
, 3
] 
[1
, 3
, 4
, 2
] 
[1
, 3
, 3
, 3
] 
[1
, 2
, 3
, 4
] 
[1
, 2
, 3
, 3
] 
[1
, 2
, 3
, 2
] 
[1
, 2
, 3
, 1
] 
[1
, 2
, 2
, 2
] 
[1
, 1
, 2
, 4
] 
[1
, 1
, 2
, 3
] 
[1
, 1
, 2
, 1
] 
[1
, 1
, 1
, 3
] 
[0
, 4
, 4
, 4
] 
[0
, 4
, 4
, 3
] 
[0
, 3
, 3
, 4
] 
[0
, 2
, 2
, 1
] 
P
er
ce
nt
ag
e 
of
 T
ot
al
 A
bu
nd
an
ce
 
Composition (ΔHexA, HexA, HexNAc, SO3) 
Input and eluate compositional percentages 
Input 
100 mM salt 
2 M salt 
26 
 
CS fragments shifts significantly to the longer length dps (>7), and an increase in 
representation of terminal dps is seen. This suggests that binding affinity increases with 
chain length, and that terminal GalNAc is preferred; this result corresponds to previous 
literature reports suggesting that WFA binds terminal GalNAc residues. 
Given the preference towards longer length dps seen in the dp 5-6 experiment, the 
WFA-CSA binding experiment was repeated with a pool of dps 5-8. Figure 10A, B, and 
C show the compositions of the input, 100 mM salt wash eluate, and 1 M salt wash 
eluate, while Figure 11 shows a comparison of profiles by percentage of total CS signal. 
1 M salt eluates were selected for analysis instead of 2 M due to technical difficulties 
with electrospray stability. Once again, 200 mM and 500 mM salt wash eluates yielded 
no significant CS signal. 
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Figure 10. Comparison of compositions between dp5-8 input library and salt eluates 
on the basis of signal intensity. CSA dp 5-6 was incubated with WFA, then eluted with 
a step gradient salt wash. Compositions are given in the form [ΔHexA, HexA, HexNAc, 
SO3]. The top fifteen compositions are shown in order of abundance. 
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Figure 11. Input and eluate compositions on the basis of percentage of total CS 
fragments. Abundances of glycans recognized by GlycReSoft 2 were summed, and 
percentages of total were taken per unique identity. Compositions comprising over 0.5% 
of the total were graphed for comparison. 
As with the dp 5-6 pool, [1, 2, 3, 3] is the primary species in the input and both 
100 mM and 1 M salt wash eluates. The increase in [0, 3, 3, 4] and [0, 4, 4, 4,] in the 
input was expected due to the inclusion of fractions containing larger dps; however, the 
intensities of these decreased with increasing salt concentration, unlike in the dp 5-6 pool 
results. This result may be explained by positing that these terminal dps actually have a 
great enough binding affinity so as to remain bound even at 1 M, necessitating a 2 M 
wash to unbind from WFA. As mentioned earlier, there may be extensive peeling 
occurring with the CS in ammonium bicarbonate storage; as this experiment was 
performed two months after the dp 5-6 experiment, peeling may be part of the reason for 
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the reduced intensities of larger dps in the input even though the pool combines fractions 
originally identified to contain dp 5-8. 
Intriguingly, the boiled WFA binding experiment, at the 1 M salt wash eluate 
(Figure 12, panel D), shows an enrichment in longer chain length and terminal dp species 
more similar to the 2 M eluate of the dp 5-6 experiment. This may suggest that at least 
one of WFA’s binding sites for CS is linear, as it appears to be intact upon denaturing. 
Such a binding site may then be more exposed when WFA is structurally denatured, 
leading to less protection for the binding interaction, and thus easier dissociation. 
However, boiled WFA does not exhibit any agglutinating activity, raising the possibility 
of multiple interactions being involved in WFA-CS binding, and suggests that whatever 
interaction is preserved after boiling is not sufficient to describe the full binding 
interaction. 
 
3-5. PNN GAG extractions 
PNN GAG extractions were performed using a protocol adapted from Deepa et al, 
2006 [27]. These adaptations aim to remove certain steps that serve only to preserve 
protein structure, a consideration which is unnecessary for GAG extraction purposes. 
Briefly, rat brains were homogenized in four buffer solutions, separating the GAGs and 
glycoproteins into a soluble GAG fraction, a membrane bound fraction, and two PNN 
fractions. The fractions were then dialyzed to remove urea and small molecule 
contaminants, and 5% of the total fraction volume was set aside for proteomics. Pronase 
digestion was then performed to remove protein before rather than after DEAE 
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chromatography, leaving only intact GAGs. The GAGs were then purified via DEAE 
weak anion exchange chromatography and ethanol precipitation.  
In order to confirm that GAG was obtained following the modifications, a sample 
was taken from a purified PNN GAG fraction and digested exhaustively with ChABC for 
disaccharide analysis. Comparison against a CS disaccharide standard indicates that CS 
was recovered successfully, and in quantities in the same order of magnitude as that 
given in literature at roughly 5 ug per 2 mg brain [27]. The modified method requires two 
fewer dialysis steps which would have added several days to each extraction. 
The content of the GAG obtained from PNN was determined via mass 
spectrometry of ChABC-digested extract 3 (Figure 12). 
 
Figure 12. Disaccharide analysis of ChABC digested PNN sample. Rat brains were 
extracted with buffers sequentially. Disaccharide analysis of ChABC-digested extract 3 
was performed to determine percent composition of PNN GAG. 
 The composition deviates significantly from literature, being composed almost 
entirely of monosulfated disaccharide, with only ~1% of the composition being either 
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unsulfated or disulfated. However, this may be due to overall low signal, resulting in the 
unsulfated or disulfated species being difficult to distinguish from noise. 
  
33 
 
DISCUSSION 
 
4-1. Conclusions 
 The primary aim of this work is to generate a workflow by which WFA-CS 
binding interactions can be characterized. In this, it has been successful at laying the 
foundations to future experiments, as the methods each yielded the data or materials they 
were designed to yield. However, in the secondary aim, to actually characterize WFA-CS 
binding, this work is only the first step and perhaps raises more questions than it answers. 
The characterization experiments yielded no simple consensus about the nature of any 
specific binding sites, but do elucidate trends to WFA-CS binding. 
Our hemagglutination inhibition assays suggest that CSA is preferred over CSC, 
which agrees well with results from CS type-specific antibody assays performed in the 
laboratory of Dr. Sabina Berretta (unpublished data). Full length CSA was seen to have a 
significantly greater inhibitory activity on WFA compared to the short fragments; this 
suggests that WFA may have multiple determinants. This is not surprising, since many 
plant lectins are or are expected to be multivalent or have multiple distinct binding sites 
[14]. This conclusion is supported by the fact that some internal fragments of CSA are 
enriched after WFA binding even after a 500 mM salt wash, suggesting some form of 
strong, specific binding of these small internal fragments, as opposed to bulk nonspecific 
binding throughout the rest of the chain. Such a situation would have intriguing 
implications regarding the ability of WFA to be specific; previously, WFA has only been 
shown to bind terminal GalNAc, but generally only terminal GalNAc was tested. 
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Multiple binding sites that differ in the region of the CS chain they bind could be a source 
of the specificity of WFA’s interactions to full length CS in the brain. 
As expected, non-reducing ends featuring terminal GalNAc were also enriched in 
addition to the unexpectedly strong binding of internal dps. There appears to be no clear 
pattern with regards to sulfation sites, like that shown above for antithrombin III and 
gp120; if anything, monosulfated CSA was enriched. Larger sizes appear to be preferred. 
Interestingly, boiled WFA, which was demonstrated to be denatured in the 
hemagglutination experiments, was also found to bind CSA fragments with high affinity, 
eluting only at 1 M salt. This may imply that amino acid residues responsible for the 
binding at the binding site are relatively close together in WFA’s sequence. 
Although not an initial aim of the project, during the course of experimentation, 
several observations were made about how CSA fragments react to the conditions of said 
experimentation. CSA digestion products appeared to go through significant GalNAc 
loss, which may be result of peeling due to storage conditions in 100 mM ammonium 
bicarbonate, and possible concentration of ammonium bicarbonate during the drying 
process. However, since ammonium bicarbonate is only mildly alkaline, it is possible that 
there is some other previously undocumented mechanism by which GalNAc loss is 
perpetuated for CS samples. 
A 1 Da reduction in the mass of CSA fragments was also observed, suggesting 
glycosylamine formation. Interestingly, the shift was exclusive to eluates from the WFA 
binding experiments, which were briefly exposed to ammonium acetate as the eluates 
were immediately dried down. Glycosylamine formation was previously described in 
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ammonium bicarbonate, and HILIC-MS with a high concentration of ammonium acetate 
may facilitate glycosylamine formation [32]. The shift was more prevalent among 
internal dp fragments that had already gone through a GalNAc loss, which is also 
consistent with the described HILIC-MS mechanism. However, the extent of the shift, 
such that the entirety of species are downshifted, is unprecedented; this suggests that the 
observed glycosylamine formation may result from a different mechanism. If the 
formation is occurring during the WFA binding experiment rather than upstream or 
downstream of it, it is difficult to determine whether the shift can affect the WFA-CSA 
binding. 
Finally, a streamlined method of purifying rat brain PNN CS was developed by 
adaptation of previous methods. The method generated a similar yield and reduced the 
time requirement of the process by several days. As the yield per brain is roughly 5 μg 
while SEC fractionation and downstream experimentation require significantly more, the 
ability to minimize the extraction time is crucial. The initial composition differs from 
previous literature, but may be the result of variability in small sample sizes or an 
inadequate amount of sample being used in disaccharide analysis. 
 
4-2. Significance 
 The biological significance of the results is that WFA likely does have more 
binding specificities than its previous description of broadly binding terminal GalNAc. 
This lends further evidence to the idea that WFA is binding a specific subpopulation of 
CS within the brain which changes with neuroplasticity and disease. Non-reducing end 
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terminal GalNAcs appear to be somewhat preferred, as expected. Within the confines of 
this particular set of experiments, no evidence was found to suggest that sulfation degree 
guides WFA binding to CS. If sulfation is involved in WFA-CS recognition, it is likely 
dependent on specific pattern. 
A significant experimental result from these investigations is the observation that 
several conditions, not previously described extensively in literature, can modify CSA 
digestions products. These conditions are important to keep in mind for future CS 
fragment-related workflows. Ammonium bicarbonate seems to cause at least the loss of 
reducing end GalNAc, and possibly further residues from the reducing end. As such, SEC 
fractions should be acidified as soon as possible to prevent this depolymerization. 
Furthermore, some part of the process in the binding experiment is causing a 1 Da 
reduction in mass which may be due to glycosylamine formation; however, it does not 
seem to match a previously described mechanism of glycosylamine formation. It would 
be prudent to desalt WFA eluates before HILIC-MS to reduce glycosylamine formation, 
and perhaps to pursue other salts by which to elute CS in the binding experiments. 
 
4-3. Future directions 
 Data analysis was made more complicated by the necessity of accommodation for 
the significant 1 Da shift; parameters set up to allow both the original mass and the lower 
mass likely increases the chances of false identifications. Furthermore, as it is uncertain 
which step of the process of the binding experiments causes the shift, it is impossible to 
rule out the possibility that this shifted species has binding properties different from the 
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original CS fragments. Thus, it would be very important to determine the cause of this 
shift to confirm that the binding is relevant to CS-WFA binding, and to allow for less 
complicated, more accurate automated data analysis. 
The WFA-CSA binding experiments should be repeated for proper verification. In 
particular, the 2 M eluates from the dp 5-8 pools should be analyzed to see if the binding 
profile trends of longer chains and terminal dps from the dp 5-6 pool bear out for larger 
pools. Binding experiment verification of the inability of CSC to bind with similar 
affinity would strengthen the hypothesis that sulfation patterns associated with 
commercial CSA are required for binding WFA. 
As no trend in sulfation extent was discovered from the binding experiment 
results, the next most likely source of specificity is sulfation pattern – that is, the same 
number of sulfates per disaccharide unit, but at different locations. To determine this 
information, tandem MS should be performed on binding experiment eluates. Also, to 
address the possibility of WFA having multiple distinct binding sites for CSA, it may be 
advisable to isolate non-reducing end species from internal fragments, incubate with the 
non-reducing end species to allow formation of the bound complex, then incubate the 
complex with internal fragments before the immobilization and salt wash. If the sites are 
not distinct, a reduction in the proportion of internal fragment would be observed 
compared to pooled incubation. If they are distinct, there would be no difference between 
the two methods of incubation. 
Previous literature has indicated that CSE-like, disulfated CS is found in PNN and 
trends with PNN activity. It may be useful to obtain and characterize the binding affinity 
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between CSE and WFA using the same methods as for CSA. Furthermore, a secreted 
protein, semaphorin 3A (Sema3A) has been found to localize to PNNs, binds to CSPGs 
with a preference for CSE, and is suggested to cause some of the biological effects of 
PNNs neuroplasticity and axonal growth [33]. It may thus prove worthwhile to obtain 
Sema3A and carry out the same experiments as were performed for WFA to determine 
whether the two bind the same CS profile, correlating concrete biological activity to the 
identified CS. 
Scaling up the PNN GAG extraction further is advisable, as digestion and SEC 
fractionation requires CS in orders of magnitudes higher amounts than are currently 
extracted. Larger-scale homogenization is one method by which the yield could be 
increased. Once an adequate amount of PNN CS is obtained, it can be subjected to the 
same binding experiments as have been performed for CSA in order to determine what 
actual binding interaction, rather than characterizing the binding of WFA itself. This 
would lead to a more direct analysis of what CS is present in PNN. 
The results from the WFA binding experiments provide further evidence that the 
WFA does bind non-reducing end GalNAc residues, which raises the possibility of 
binding specificity arising from chain termination. One method by which to probe this 
question is to digest CS from brain extracts with hyaluronidase. Bovine testicular 
hyaluronidase cleaves at the same site as chondroitinase ABC, but is more resistant to 
tissue-derived samples and cleaves into fragments no smaller than dp 4, assuring that if 
there is a difference in non-reducing end, it would be visible, as pentasaccharides and 
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heptasaccharides would give indications that the non-reducing end terminates in a 
GalNAc. 
It may also be useful to use whole brain CS in WFA binding experiments, 
especially should it prove difficult to procure adequate amounts of CS for SEC 
fractionation. Whole brain CS analysis may also shed light on whether there are multiple 
binding sites via the implementation of some form of digestion protection assay. Finally, 
if possible, extraction from human brains and the downstream analysis experiments can 
be attempted as well to further pin down the exact CS it is binding in human brains and in 
schizophrenia. 
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